US Stock MarketDetailed Quotes

Apyx Medical (APYX)

Watchlist
  • 3.670
  • +0.110+3.09%
Close May 8 15:59 ET
  • 3.670
  • 0.0000.00%
Post 16:10 ET
153.68MMarket Cap-16.68P/E (TTM)

Apyx Medical (APYX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
32.45%12.49M
9.86%52.84M
34.75%19.16M
12.10%12.88M
-6.39%11.37M
-7.95%9.43M
-8.11%48.1M
-3.00%14.22M
-4.08%11.49M
-10.47%12.15M
Operating revenue
32.45%12.49M
9.86%52.84M
34.75%19.16M
12.10%12.88M
-6.39%11.37M
-7.95%9.43M
-8.11%48.1M
-3.00%14.22M
-4.08%11.49M
-10.47%12.15M
Cost of revenue
21.25%4.57M
5.65%19.8M
36.27%7.17M
1.04%4.58M
-7.86%4.29M
-12.34%3.77M
0.82%18.74M
-8.29%5.26M
13.38%4.53M
8.53%4.66M
Gross profit
39.89%7.93M
12.55%33.04M
33.86%12M
19.31%8.3M
-5.47%7.08M
-4.77%5.67M
-13.03%29.36M
0.39%8.96M
-12.84%6.95M
-19.25%7.49M
Operating expense
1.38%8.84M
-18.08%39.49M
-0.20%11.99M
-13.79%9.13M
-25.94%9.66M
-30.63%8.72M
-10.25%48.21M
-18.31%12.01M
-16.06%10.59M
-1.26%13.04M
Selling and administrative expenses
2.01%8.07M
-16.25%36.12M
1.37%11.04M
-11.85%8.33M
-23.96%8.83M
-29.15%7.91M
-10.66%43.13M
-18.10%10.9M
-15.70%9.45M
-1.97%11.62M
-General and administrative expense
2.01%8.07M
-16.25%36.12M
1.37%11.04M
-11.85%8.33M
-23.96%8.83M
-29.15%7.91M
-10.66%43.13M
-18.10%10.9M
-15.70%9.45M
-1.97%11.62M
Research and development costs
-4.85%765K
-33.60%3.37M
-15.49%944K
-29.86%801K
-42.13%824K
-42.45%804K
-6.62%5.08M
-20.38%1.12M
-18.95%1.14M
4.94%1.42M
Operating profit
70.14%-911K
65.79%-6.45M
100.36%11K
77.11%-832K
53.60%-2.57M
53.88%-3.05M
5.54%-18.85M
47.23%-3.05M
21.61%-3.64M
-41.25%-5.55M
Net non-operating interest income expense
-4.94%-1.13M
-4.19%-4.48M
13.69%-1.17M
-6.46%-1.12M
-12.85%-1.12M
-18.98%-1.07M
-176.24%-4.3M
-101.93%-1.36M
-212.46%-1.05M
-171.43%-988K
Non-operating interest income
-19.74%244K
-31.01%1.11M
-20.41%234K
-22.75%292K
-36.67%278K
-38.59%304K
74.38%1.61M
-33.63%294K
52.42%378K
145.25%439K
Non-operating interest expense
-0.51%1.37M
-5.38%5.59M
-14.88%1.41M
-1.26%1.41M
-2.38%1.39M
-1.43%1.38M
138.38%5.91M
48.12%1.65M
144.62%1.43M
162.80%1.43M
Other net income (expense)
36K
157.14%92K
109.82%16K
216.67%76K
-171.24%-161K
94.72%-163K
226.32%24K
-100.03%-1K
Special income (charges)
----
----
----
----
----
----
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
----
----
----
----
----
----
----
----
----
--0
Other non- operating income (expenses)
--36K
157.14%92K
109.82%16K
216.67%76K
----
----
-125.88%-161K
---163K
226.32%24K
-100.15%-1K
Income before tax
51.49%-2M
53.51%-10.84M
74.92%-1.15M
59.76%-1.88M
43.56%-3.69M
45.30%-4.12M
-9.52%-23.31M
52.08%-4.57M
6.59%-4.66M
-585.83%-6.54M
Income tax
191.84%143K
7.14%270K
5.62%94K
30.00%78K
-2.00%49K
-7.55%49K
110.36%252K
2.30%89K
118.87%60K
-24.24%50K
Net income
48.63%-2.14M
52.86%-11.11M
73.38%-1.24M
58.62%-1.96M
43.24%-3.74M
45.03%-4.17M
-24.98%-23.56M
51.59%-4.66M
-1.05%-4.72M
-546.32%-6.59M
Net income continuous Operations
48.63%-2.14M
52.86%-11.11M
73.38%-1.24M
58.62%-1.96M
43.24%-3.74M
45.03%-4.17M
-24.98%-23.56M
51.59%-4.66M
-1.05%-4.72M
-546.32%-6.59M
Minority interest income
-59.09%-35K
210.42%106K
290.32%59K
238.10%29K
233.33%40K
-57.14%-22K
29.93%-96K
-82.35%-31K
54.35%-21K
-20.00%-30K
Net income attributable to the parent company
49.20%-2.11M
52.22%-11.21M
71.93%-1.3M
57.81%-1.98M
42.37%-3.78M
45.22%-4.15M
-25.38%-23.46M
51.83%-4.63M
-1.60%-4.7M
-559.56%-6.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.20%-2.11M
52.22%-11.21M
71.93%-1.3M
57.81%-1.98M
42.37%-3.78M
45.22%-4.15M
-25.38%-23.46M
51.83%-4.63M
-1.60%-4.7M
-559.56%-6.56M
Basic earnings per share
50.00%-0.05
59.09%-0.27
75.00%-0.03
64.29%-0.05
52.63%-0.09
54.55%-0.1
-22.22%-0.66
57.14%-0.12
-7.69%-0.14
-533.33%-0.19
Diluted earnings per share
50.00%-0.05
59.09%-0.27
75.00%-0.03
64.29%-0.05
52.63%-0.09
54.55%-0.1
-22.22%-0.66
57.14%-0.12
-7.69%-0.14
-533.33%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 32.45%12.49M9.86%52.84M34.75%19.16M12.10%12.88M-6.39%11.37M-7.95%9.43M-8.11%48.1M-3.00%14.22M-4.08%11.49M-10.47%12.15M
Operating revenue 32.45%12.49M9.86%52.84M34.75%19.16M12.10%12.88M-6.39%11.37M-7.95%9.43M-8.11%48.1M-3.00%14.22M-4.08%11.49M-10.47%12.15M
Cost of revenue 21.25%4.57M5.65%19.8M36.27%7.17M1.04%4.58M-7.86%4.29M-12.34%3.77M0.82%18.74M-8.29%5.26M13.38%4.53M8.53%4.66M
Gross profit 39.89%7.93M12.55%33.04M33.86%12M19.31%8.3M-5.47%7.08M-4.77%5.67M-13.03%29.36M0.39%8.96M-12.84%6.95M-19.25%7.49M
Operating expense 1.38%8.84M-18.08%39.49M-0.20%11.99M-13.79%9.13M-25.94%9.66M-30.63%8.72M-10.25%48.21M-18.31%12.01M-16.06%10.59M-1.26%13.04M
Selling and administrative expenses 2.01%8.07M-16.25%36.12M1.37%11.04M-11.85%8.33M-23.96%8.83M-29.15%7.91M-10.66%43.13M-18.10%10.9M-15.70%9.45M-1.97%11.62M
-General and administrative expense 2.01%8.07M-16.25%36.12M1.37%11.04M-11.85%8.33M-23.96%8.83M-29.15%7.91M-10.66%43.13M-18.10%10.9M-15.70%9.45M-1.97%11.62M
Research and development costs -4.85%765K-33.60%3.37M-15.49%944K-29.86%801K-42.13%824K-42.45%804K-6.62%5.08M-20.38%1.12M-18.95%1.14M4.94%1.42M
Operating profit 70.14%-911K65.79%-6.45M100.36%11K77.11%-832K53.60%-2.57M53.88%-3.05M5.54%-18.85M47.23%-3.05M21.61%-3.64M-41.25%-5.55M
Net non-operating interest income expense -4.94%-1.13M-4.19%-4.48M13.69%-1.17M-6.46%-1.12M-12.85%-1.12M-18.98%-1.07M-176.24%-4.3M-101.93%-1.36M-212.46%-1.05M-171.43%-988K
Non-operating interest income -19.74%244K-31.01%1.11M-20.41%234K-22.75%292K-36.67%278K-38.59%304K74.38%1.61M-33.63%294K52.42%378K145.25%439K
Non-operating interest expense -0.51%1.37M-5.38%5.59M-14.88%1.41M-1.26%1.41M-2.38%1.39M-1.43%1.38M138.38%5.91M48.12%1.65M144.62%1.43M162.80%1.43M
Other net income (expense) 36K157.14%92K109.82%16K216.67%76K-171.24%-161K94.72%-163K226.32%24K-100.03%-1K
Special income (charges) --------------------------0--0--0--0
-Gain on sale of property,plant,equipment --------------------------------------0
Other non- operating income (expenses) --36K157.14%92K109.82%16K216.67%76K---------125.88%-161K---163K226.32%24K-100.15%-1K
Income before tax 51.49%-2M53.51%-10.84M74.92%-1.15M59.76%-1.88M43.56%-3.69M45.30%-4.12M-9.52%-23.31M52.08%-4.57M6.59%-4.66M-585.83%-6.54M
Income tax 191.84%143K7.14%270K5.62%94K30.00%78K-2.00%49K-7.55%49K110.36%252K2.30%89K118.87%60K-24.24%50K
Net income 48.63%-2.14M52.86%-11.11M73.38%-1.24M58.62%-1.96M43.24%-3.74M45.03%-4.17M-24.98%-23.56M51.59%-4.66M-1.05%-4.72M-546.32%-6.59M
Net income continuous Operations 48.63%-2.14M52.86%-11.11M73.38%-1.24M58.62%-1.96M43.24%-3.74M45.03%-4.17M-24.98%-23.56M51.59%-4.66M-1.05%-4.72M-546.32%-6.59M
Minority interest income -59.09%-35K210.42%106K290.32%59K238.10%29K233.33%40K-57.14%-22K29.93%-96K-82.35%-31K54.35%-21K-20.00%-30K
Net income attributable to the parent company 49.20%-2.11M52.22%-11.21M71.93%-1.3M57.81%-1.98M42.37%-3.78M45.22%-4.15M-25.38%-23.46M51.83%-4.63M-1.60%-4.7M-559.56%-6.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.20%-2.11M52.22%-11.21M71.93%-1.3M57.81%-1.98M42.37%-3.78M45.22%-4.15M-25.38%-23.46M51.83%-4.63M-1.60%-4.7M-559.56%-6.56M
Basic earnings per share 50.00%-0.0559.09%-0.2775.00%-0.0364.29%-0.0552.63%-0.0954.55%-0.1-22.22%-0.6657.14%-0.12-7.69%-0.14-533.33%-0.19
Diluted earnings per share 50.00%-0.0559.09%-0.2775.00%-0.0364.29%-0.0552.63%-0.0954.55%-0.1-22.22%-0.6657.14%-0.12-7.69%-0.14-533.33%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More